Renovaro Biosciences Inc. (NASDAQ: RENB)
$1.41
+0.0100 ( +0.71% ) 143.7K
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Market Data
Open
$1.41
Previous close
$1.40
Volume
143.7K
Market cap
$218.58M
Day range
$1.39 - $1.45
52 week range
$0.66 - $5.25
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 27, 2024 |
| 8-k | 8K-related | 16 | Jun 21, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | May 30, 2024 |
| 8-k | 8K-related | 14 | May 24, 2024 |
| 8-k | 8K-related | 14 | May 24, 2024 |
| 10-q | Quarterly Reports | 74 | May 15, 2024 |
| 8-k | 8K-related | 13 | Apr 30, 2024 |